Which then raises the question - why? Why would the US Dept Defence fund Penthrox. Maybe they can bypass the FDA but then again, I wonder how many hysterectomies and osteo related knee procedures are being done under US military medical coverage?
I suspect there is either some MVP money underpinning this research or the research is done for some universal benefit. If its the latter then its next to useless as we know that Penthrox does not sell without concerted efforts by a sales team.
All false hope I'm afraid.
Another Positive Study, page-168
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
0.005(1.14%) |
Mkt cap ! $50.13M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.5¢ | 42.0¢ | $74.04K | 171.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40558 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 1342 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |